MedPath

Towards the assessment of metabolic biomarkers and creatine uptake and turnover in skeletal muscles of patients with Facioscapulohumeral muscular dystrophy using MR spectroscopy

Phase 2
Conditions
muscle disease
muscular dystrophy
10028302
Registration Number
NL-OMON30391
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
35
Inclusion Criteria

FSHD patients: clinically affected patients with a genetically confirmed diagnosis, moderate severity of the disease, informed consent.
Heatlhy volunteers: informed consent

Exclusion Criteria

All subjects: kidney or liverproblems (present or past), diabetes, wheelchair bound. MR contra-indication: pacemaker, cerebral clips, metal splinters, neuro stimulator, cardiac arythmias, epilepsy, severe claustrofobia, pregnancy.
Healthy volunteers: skeletal muscle problems or disease

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath